Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intra-nasal GSK2245035 in Adults With Allergic Asthma
NCT03707678Phase 2Withdrawn
- Sponsor
- GSK
- Start
- Jan 2019
- Primary completion
- Dec 2019
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of GSK2245035 in allergic asthma, sponsored by GSK. Planned start Jan 2019; status: withdrawn.
02
Drugs
GSK2245035
03
Conditions
allergic asthma
Beyond the preview
Go deeper on NCT03707678.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03707678.